Highlights
• TGF-β signaling in fibrosis diseases modeled within 3D organoids.
• TGF-β signaling in Epithelial-mesenchymal transition of cancer diseases modeled.
• Applications of 3D organoids model in drug discovery and personalized medicine.
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
• TGF-β signaling in fibrosis diseases modeled within 3D organoids.
• TGF-β signaling in Epithelial-mesenchymal transition of cancer diseases modeled.
• Applications of 3D organoids model in drug discovery and personalized medicine.
The Transforming Growth Factor-beta (TGF-β) signaling pathway is a master regulator of cellular processes, including proliferation, differentiation and apoptosis, with profound implications for tissue homeostasis and disease pathogenesis. This review delves into the mechanisms and applications of TGF-β signaling within organoids, three-dimensional (3D) cultures that mimic human tissue architecture and function. We systematically explore the multifaceted role of TGF-β in organoid initiation, growth, and differentiation, highlighting its influence on stem cell self-renewal and lineage specification. The interplay between TGF-β and other signaling pathways, such as Wnt/β-catenin and Notch, is critical for maintaining tissue homeostasis and regulating stem cell niches. Furthermore, we discuss the significance of TGF-β signaling in modeling diseases like cancer and fibrosis, where its dysregulation is often implicated. Modulating TGF-β signaling in organoids holds vast therapeutic potential, offering insights into disease pathogenesis, predicting drug responses, and developing personalized treatment strategies. As our understanding of TGF-β signaling and organoid technology advances, these systems hold promise for groundbreaking biomedical research, potentially revolutionizing regenerative medicine and personalized therapeutics.

The articles published in this open access journal are distributed under the termsof the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution andreproduction in any medium, provided the original work is properly cited.
Comments on this article